|
|
Weekly News Digest
 |
July 2, 2013 — In addition to this week's NewsBreaks article and the monthly NewsLink Spotlight, Information Today, Inc. (ITI) offers Weekly News Digests that feature recent product news and company announcements. Watch for additional coverage to appear in the next print issue of Information Today. For other up-to-the-minute news, check out ITI’s Twitter account: @ITINewsBreaks.
CLICK HERE to view more Weekly News Digest items.
|
Thomson Reuters Offers Clinical Trial Intelligence Solutions
The Intellectual Property & Science business of Thomson Reuters introduced two clinical trial intelligence software solutions for R&D professionals: Cortellis Clinical Trials Intelligence and Cortellis Site Performance Advisor.These solutions improve clinical trials, speed up product development and release, and help professionals strengthen portfolios and R&D strategy. Thomson Reuters released a white paper called “Four Ways to Accelerate Your Clinical Portfolio Strategy” that describes “ways to accelerate clinical trial design through analytic approaches that leverage advanced technology,” by looking at drug lifecycles to obtain curated data and discover competitive products and drug safety. The Clinical Trials Intelligence solution offers access to more than 130,000 worldwide trials for biologics, diagnostics, biomarkers, medical devices, and drugs for rare diseases. Also available are thousands of press releases, literature articles, drug development articles, meeting abstracts, conference reports, and analyst and investor meeting transcripts. The solution features a trial timeline viewer that shows a constantly updated longitudinal view of a company or drug’s trial start date and expected, actual, or projected end date. Users can access the solution on Thomson Reuters’ web portal or its application programming interface (API). The Site Performance Advisor offers pharmaceutical and contract resource organization executives access to recruiting sites. It provides information on countries best suited for recruitment and that have relevant patient populations, as well as analytics that show countries that have had successful clinical trials. Source: Thomson Reuters
Send correspondence concerning the Weekly News Digest to NewsBreaks Editor
Brandi Scardilli
|